Sublingual Versus Endovenous Fentanyl for Pain Treatment in Trauma Patients in the Emergency Room

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

108 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-12-01

Study Completion Date

2017-05-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the non-inferiority of the efficacy of sublingual given fentanyl versus endovenous given fentanyl for patients in the emergency departement.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Sublingual Versus Endovenous Fentanyl for the Prehospital Analgesia in Patients With Limb Trauma on the Slope

NCT03080350

Acute Pain Due to Trauma

COMPLETED PHASE4

Study to Explore Effectiveness of Sublingual Fentanyl Spray in Emergency Department Patients With Acute Pain

NCT02137525

Acute Pain

WITHDRAWN PHASE2

Sublingual Sufentanil vs Intravenous Fentanyl for Acute Pain in the Ambulatory Surgery Center

NCT04177862

Pain Pain, Acute Anesthesia

COMPLETED PHASE4

Determination of Analgesic Equipotent Doses of Inhaled Metoxyflurane vs. Intravenous Fentanyl

NCT03894800

Acute Pain Trauma Hypovolemia

COMPLETED PHASE4

Intranasal Sufentanil Versus Intravenous Morphine for the Management of Acute Pain

NCT03224039

Acute Pain

UNKNOWN PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Fentanyl endovenous (ev) is an excellent analgesic drug for pain relief in acute traumatic pain. Fentanyl sublingual (Abstral ®) is an excellent analgesic drug in the breakthrough pain relief in oncologic patients.

The immediate (10 minutes) effect and the ease of administration of sublingual fentanyl could be a possibility for a fast pain relief in remote areas such as mountain rescue missions.

Patients will be recruited according to a randomized list to fentanyl ev or fentanyl sublingual versus placebo oral or placebo ev.

Safety issues like control of vital signs will be warranted

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Pain Due to Trauma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fentanyl sublingual + Placebo ev

Fentanyl 100 µg sublingual in acute sever pain + NaCl 0,9% endovenous to mimic fentanyl ev

Group Type EXPERIMENTAL

Fentanyl sublingual

Intervention Type DRUG

Fentanyl sublingual

Placebo ev

Intervention Type DRUG

Saline

Fentanyl ev + Placebo sublingual

Fentanyl ev in acute sever pain + Sugar pill manufactured to mimic fentanyl sublingual

Group Type ACTIVE_COMPARATOR

Fentanyl ev

Intervention Type DRUG

Fentanyl ev

Placebo sublingual

Intervention Type DRUG

Placebo sublingual

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fentanyl sublingual

Intervention Type DRUG

Fentanyl ev

Intervention Type DRUG

Placebo sublingual

Intervention Type DRUG

Placebo ev

Saline

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Abstral Fentanest Placebo Saline

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Trauma on the limbs with a pain score of 4 or more
* ASA I - II

Exclusion Criteria

* children \< 18 years
* cognitive impairment: brain injury, intoxication, analgesia
* weight under 50 kg and more then 100 kg
* other injuries like chest trauma with respiratory insufficiency, suspect liver or spleen injury, amputation;
* chronic analgesic use or misuse
* allergy
* fear of needles
* pregnancy
* speech difficulties

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No